Integrative Multi‐omics Approaches Identify Biomarkers Associated with Progression from Arthralgia to Rheumatoid Arthritis
BACKGROUND: Arthralgia, an early manifestation preceding definite rheumatoid arthritis (RA), represents a critical window to identify high-risk individuals and implement timely interventions. However, the immunopathological mechanisms underlying the transition from arthralgia to established RA remain incompletely defined. METHODS: We employed a multi-omics strategy integrating peripheral immune cell phenotyping, serum proteomics, and autoantibody profiling to investigate the immunopathological continuum from preclinical to established RA. A prospective cohort of 346 patients with recent-onset arthralgia was enrolled. Participants included healthy controls, self-limiting arthralgia (SLA), arthralgia at risk of RA (ARI), early RA, and established RA. RA development in ARI was ascertained through 24-month follow-up. RESULTS: Compared with SLA, ARI showed immune dysregulation, including reduced Tregs and a lower Treg/Th17 ratio, with related changes persisting into early RA. Serum proteomics revealed upregulation of C5, A1BG, RPUSD4, WDR87 and FUBP2, which showed inverse associations with Tregs. Autoantibody profiling identified stage-specific reactivity, with ARI showing elevated antibodies against stress-related proteins. Within 24 months, 18.4% of ARI progressed to RA (converters). Baseline immunophenotypic differences between converters and non-converters were comparable, while longitudinal paired analyses revealed a reduction in Tregs and Treg/Th17 ratio. Treg/Th17 ratio (AUC = 0.734) outperformed anti-CCP (AUC = 0.611) in discriminating ARI from SLA, particularly in ACPA-negative patients (AUC = 0.729). Combining Tregs, anti-CCP and Treg/Th17 ratio improved classification performance (AUC = 0.783). CONCLUSIONS: These findings delineate a critical transition from reversible immune dysregulation to established autoimmunity along the arthralgia-RA continuum, suggesting that Treg-related dysregulation may be associated with progression toward persistent inflammatory arthritis.
Authors
- H Y Wang
- X M Wang
- Xiaoyan Xing
- Rui Yan (ORCID: https://orcid.org/0000-0002-8495-1289)
- Z A Li
- Xuyang Zhao (ORCID: https://orcid.org/0000-0002-4470-7986)
- Sitian Zang (ORCID: https://orcid.org/0009-0005-1182-2020)
- Yudong Liu (ORCID: https://orcid.org/0000-0002-5153-3400)
- Q Wang
- Siyue Yu (ORCID: https://orcid.org/0000-0001-7360-2406)
- Y G Su
- Yipeng Han
- Min Li
- Jing Chi
- Xiaobo Yu
- Yuan Jia
- Xiaomei Zhang
- Gong Cheng
- Bo Huang
- Yuebo Jin
- Minghua Zhan (ORCID: https://orcid.org/0009-0000-1535-8222)
- Jing He (ORCID: https://orcid.org/0000-0003-3904-8928)
Institutions
- Hebei North University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Beijing Biocytogen (China) (CN)
- Peking University People's Hospital (CN)
- Peking University Shenzhen Hospital (CN)
- National Center for Clinical Laboratories (CN)
- Beijing Proteome Research Center (CN)
- Case Western Reserve University (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2026-04-20
- DOI
- https://doi.org/10.1002/art.70194
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00